HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; ...
Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...
The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...
A tool for spotting pancreatic cancer in routine CT scans has had promising results, one example of how China is racing to ...
Scientists created an immunotherapy that tracks pancreatic cancer even after it spreads. The breakthrough treatment works in ...
A new tool can help physicians determine which patients with localized pancreatic neuroendocrine tumors (PanNETs) have an ...
EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the ...
Final results from the phase 3 CASSANDRA trial presented at the 2025 ASCO Meeting show that the neoadjuvant chemotherapy ...
A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...
Addressing the "Apple Community" in a statement, Jobs said his doctors think they have found the reason behind his weight loss: "a hormone imbalance that has been 'robbing' me of ...